Highlights and Quick Summary
- R&D Expenses for the quarter ending June 30, 2022 was $12 Million (a -6.32% decrease compared to previous quarter)
- Year-over-year quarterly R&D Expenses decreased by -7.48%
- Annual R&D Expenses for 2021 was $50.1 Million (a 20.4% increase from previous year)
- Annual R&D Expenses for 2020 was $41.6 Million (a -37.53% decrease from previous year)
- Annual R&D Expenses for 2019 was $66.7 Million (a -81.8% decrease from previous year)
- Twelve month R&D Expenses ending June 30, 2022 was $50.7 Million (a -3.3% decrease compared to previous quarter)
- Twelve month trailing R&D Expenses increased by 5.98% year-over-year
Trailing R&D Expenses for the last four month:
30 Jun '22 | 31 Mar '22 | 31 Dec '21 | 30 Sep '21 |
---|---|---|---|
$50.7 Million | $52.4 Million | $50.1 Million | $47.8 Million |
Visit stockrow.com/PGEN
for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow
statement with 10 years of data, and state-of-the-art screener.
Historical R&D Expenses of Precigen, Inc.
Most recent R&D Expensesof PGEN including historical data for past 10 years.Interactive Chart of R&D Expenses of Precigen, Inc.
Precigen, Inc. R&D Expenses for the past 10 Years (both Annual and Quarterly)
(All values are in $ million)
Year | Q1 | Q2 | Q3 | Q4 | Fiscal Year |
---|---|---|---|---|---|
2022 | $11.95 | $12.76 | – | – | – |
2021 | $13.02 | $12.92 | $13.68 | $10.52 | $50.14 |
2020 | $10.67 | $10.17 | $9.47 | $11.33 | $41.64 |
2019 | $-14.18 | $25.67 | $28.24 | $26.94 | $66.67 |
2018 | $208.81 | $44.89 | $42.05 | $37.27 | $366.25 |
2017 | $4.51 | $36.47 | $34.01 | $34.18 | $143.21 |
2016 | $28.87 | $29.04 | $28.38 | $25.86 | $112.14 |
2015 | $26.2 | $21.6 | $20.38 | $79.31 | $147.48 |
2014 | $17.64 | $14.85 | $14.43 | $12.06 | $58.98 |
2013 | $12.55 | $10.67 | $13.51 | $11.41 | $48.14 |
2012 | – | – | $14.36 | $17.64 | $64.03 |
2011 | – | – | – | – | $70.23 |
Business Profile of Precigen, Inc.
Sector: Healthcare
Industry: Biotechnology